A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants
Clinical trial NCT03329209 · COMPLETED
Trial details
- NCT number
- NCT03329209
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2018-07-26
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.